《黄栀子花精油》、《枳壳花精油》两项团体标准全国首发
Jing Ji Guan Cha Wang·2025-12-12 07:07

Core Viewpoint - The release of the group standards for "Huang Zhi Zi Flower Essential Oil" and "Zhi Ke Flower Essential Oil" marks a significant advancement in the Chinese herbal essential oil industry, addressing existing market challenges and setting a foundation for quality and standardization [1][2]. Group 1: Industry Development - The global demand for natural and healthy ingredients is driving the growth of the plant extract industry, with the market size projected to reach approximately $42.245 billion in 2024 and expected to grow to $79.449 billion by 2031, reflecting a compound annual growth rate (CAGR) of 9.24% from 2025 to 2031 [1]. - Unique Chinese resources such as Huang Zhi Zi and Zhi Ke Flower exhibit significant high-value conversion potential due to their unique chemical compositions and applications in various sectors, including natural daily chemicals, aromatherapy, and health food additives [2]. Group 2: Standardization and Quality Assurance - The lack of unified quality and technical standards has led to three major challenges in the market: a trust crisis due to inconsistent product quality, undervaluation of high-quality resources lacking internationally recognized quality certifications, and difficulties in integrating the entire industry chain from cultivation to product innovation [2]. - The newly established standards introduce a quantitative index system based on characteristic components, scientifically defining the content range of key components such as West Pine A and trans-nerol, thereby establishing objective quality evaluation benchmarks [2]. Group 3: Strategic Initiatives - The company aims to leverage the release of these standards to systematically integrate existing research data and standard experiences, advancing strategies in research and development, application, and industry collaboration [3]. - Future goals include building an open and collaborative industrial ecosystem by deepening partnerships with top research clinical institutions, thereby facilitating the output and transformation of value from Chinese plant resources [3].